# DHA Supplementation for Lactating Mothers

> **NCT01732874** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 27 (actual)

## Conditions studied

- Docosohexaenoic Acid Supplementation of Mothers to

## Interventions

- **DRUG:** Expecta 200 mg
- **DRUG:** Expecta 1 gram

## Key facts

- **NCT ID:** NCT01732874
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2018-07-16
- **Final completion:** 2018-07-16
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01732874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01732874, "DHA Supplementation for Lactating Mothers". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01732874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*